Adverse Effect of High Glucose Concentration on Stem Cell Therapy
Abstract
Stem cell therapy could have great potential for the treatment of a wide variety of diseases. Stem cells might have the ability to differentiate into a widespread cell types, and to repopulate and revitalize the damaged cells with healthy tissue, and improve its performance. We provide here the evidence supporting the critical use of stem cell as a treatment in disease conditions existing with high glucose complaint such as diabetes. The reduction of glucose stimulated cell proliferation and high glucose enhanced apoptosis in rat model, which may be a problem in therapeutic strategies based on ex vivo expansion of stem cell, and may also propagate the development of osteoporosis in high glucose complaint such as diabetes. This leads to the hypothesis that, high glucose could be more deleterious to stem cell therapy that may be due to the aggravation of oxidative stress triggered by high glucose. These findings may help to understand the possible reasons associated with high glucose induced detrimental effects on stem cells as well as provide novel therapeutic strategies for preventing the adverse effects of glucose on the development and progression of stem cells in patients with diabetes.
Larijani, B., et al., Stem cell therapy in treatment of different diseases. Acta Med Iran, 2012. 50(2): p. 79-96.
Brehm, M., B. Stanske, and B.E. Strauer, Therapeutic potential of stem cells in elderly patients with cardiovascular disease. Exp Gerontol, 2008. 43(11): p. 1024-32.
Hassiotou, F., et al., Breastmilk is a novel source of stem cells with multilineage differentiation potential. Stem Cells, 2012. 30(10): p. 2164-74.
Ding, V., A.B. Choo, and S.K. Oh, Deciphering the importance of three key media components in human embryonic stem cell cultures. Biotechnol Lett, 2006. 28(7): p. 491-5.
Scheepers, A., H.G. Joost, and A. Schurmann, The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN J Parenter Enteral Nutr, 2004. 28(5): p. 364-71.
Liu, J., et al., High Levels of Glucose Induced the Caspase-3/PARP Signaling Pathway, Leading to Apoptosis in Human Periodontal Ligament Fibroblasts. Cell Biochem Biophys, 2012.
Robertson, R.P. and J.S. Harmon, Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med, 2006. 41(2): p. 177-84.
Stolzing, A., N. Coleman, and A. Scutt, Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res, 2006. 9(1): p. 31-5.
Chang, J., et al., Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes, 2010. 59(11): p. 2949-59.
Kassem, M., Stem cells: potential therapy for age-related diseases. Ann N Y Acad Sci, 2006. 1067: p. 436-42.
Strotmeyer, E.S., et al., Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care, 2006. 29(2): p. 306-11.
Butler, A.E., et al., Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 2003. 52(1): p. 102-10.
Yoon, K.H., et al., Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab, 2003. 88(5): p. 2300-8.
Sakuraba, H., et al., Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia, 2002. 45(1): p. 85-96.
Marinkovic, T., M. Sysi-Aho, and M. Oresic, Integrated Model of Metabolism and Autoimmune Response in beta-Cell Death and Progression to Type 1 Diabetes. PLoS One, 2012. 7(12): p. e51909.
Mathis, D., L. Vence, and C. Benoist, beta-Cell death during progression to diabetes. Nature, 2001. 414(6865): p. 792-8.
Robertson, R.P., et al., Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes, 2004. 53 Suppl 1: p. S119-24.
Stolzing, A., E. Bauer, and A. Scutt, Suspension cultures of bone-marrow-derived mesenchymal stem cells: effects of donor age and glucose level. Stem Cells Dev, 2012. 21(14): p. 2718-23.
Liang, C., et al., Responses of human adipose-derived mesenchymal stem cells to chemical microenvironment of the intervertebral disc. J Transl Med, 2012. 10: p. 49.
Elseberg, C.L., et al., Microcarrier-based expansion process for hMSCs with high vitality and undifferentiated characteristics. Int J Artif Organs, 2012. 35(2): p. 93-107.
Kim, Y.J., et al., miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. Stem Cells Dev, 2012. 21(10): p. 1749-60.
Khan, M., et al., Growth factor preconditioning increases the function of diabetes-impaired mesenchymal stem cells. Stem Cells Dev, 2011. 20(1): p. 67-75.
Li, Y.M., et al., Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun, 2007. 363(1): p. 209-15.
Keats, E. and Z.A. Khan, Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose. PLoS One, 2012. 7(6): p. e38752.
Mochizuki, H., Y. Ohnuki, and H. Kurosawa, Effect of glucose concentration during embryoid body (EB) formation from mouse embryonic stem cells on EB growth and cell differentiation. J Biosci Bioeng, 2011. 111(1): p. 92-7.
Howard, A.C., et al., A novel cellular defect in diabetes: membrane repair failure. Diabetes, 2011. 60(11): p. 3034-43.
Kim, Y.H., J.S. Heo, and H.J. Han, High glucose increase cell cycle regulatory proteins level of mouse embryonic stem cells via PI3-K/Akt and MAPKs signal pathways. J Cell Physiol, 2006. 209(1): p. 94-102.
McCance, D.R., et al., Diagnosing diabetes mellitus--do we need new criteria? Diabetologia, 1997. 40(3): p. 247-55.
Wasfy, J.H., Childhood vaccination and type 1 diabetes. N Engl J Med, 2004. 351(3): p. 298.
Hviid, A., et al., Childhood vaccination and type 1 diabetes. N Engl J Med, 2004. 350(14): p. 1398-404.
DeStefano, F., et al., Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics, 2001. 108(6): p. E112.
Milne, L.M., Difficulties in assessing the relationship, if any, between mumps vaccination and diabetes mellitus in childhood. Vaccine, 2000. 19(9-10): p. 1018-25.
Dahlquist, G. and L. Gothefors, The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia, 1995. 38(7): p. 873-4.
Albers, J.W., et al., Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care, 2010. 33(5): p. 1090-6.
Ratner, R.E., Glycemic control in the prevention of diabetic complications. Clin Cornerstone, 2001. 4(2): p. 24-37.
Aronson, D., Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol, 2008. 45: p. 1-16.
Burns, C.J., S.J. Persaud, and P.M. Jones, Diabetes mellitus: a potential target for stem cell therapy. Curr Stem Cell Res Ther, 2006. 1(2): p. 255-66.
Phadnis, S.M., et al., Mesenchymal stem cells derived from bone marrow of diabetic patients portrait unique markers influenced by the diabetic microenvironment. Rev Diabet Stud, 2009. 6(4): p. 260-70.
Gu, W., et al., Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes. Diabetes Care, 2012. 35(7): p. 1413-9.
Fadini, G.P., et al., Amelioration of glucose control mobilizes circulating pericyte progenitor cells in type 2 diabetic patients with microangiopathy. Exp Diabetes Res, 2012. 2012: p. 274363.
Li, L., et al., Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves beta-cell function in Chinese patients with new onset of type 1 diabetes. J Clin Endocrinol Metab, 2012. 97(5): p. 1729-36.
Ruiz-Salmeron, R., et al., Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Cell Transplant, 2011. 20(10): p. 1629-39.
Zhao, Y., et al., Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med, 2012. 10: p. 3.
Jiang, R., et al., Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med, 2011. 5(1): p. 94-100.
Bhansali, A., et al., Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells Dev, 2009. 18(10): p. 1407-16.
Yue, T., et al., High glucose induces differentiation and adipogenesis in porcine muscle satellite cells via mTOR. BMB Rep, 2010. 43(2): p. 140-5.
Li, H., L.S. Jiang, and L.Y. Dai, High glucose potentiates collagen synthesis and bone morphogenetic protein-2-induced early osteoblast gene expression in rat spinal ligament cells. Endocrinology, 2010. 151(1): p. 63-74.
Gopalakrishnan, V., et al., Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol, 2006. 84(1): p. 93-101.
Kim, Y.H. and H.J. Han, Synergistic effect of high glucose and ANG II on proliferation of mouse embryonic stem cells: involvement of PKC and MAPKs as well as AT1 receptor. J Cell Physiol, 2008. 215(2): p. 374-82.
Aguiari, P., et al., High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci U S A, 2008. 105(4): p. 1226-31.
Stanekzai, J., E.R. Isenovic, and S.A. Mousa, Treatment options for diabetes: Potential role of stem cells. Diabetes Res Clin Pract, 2012. 98(3): p. 361-8.
Weir, G.C., C. Cavelti-Weder, and S. Bonner-Weir, Stem cell approaches for diabetes: towards beta cell replacement. Genome Med, 2011. 3(9): p. 61.
Burns, C.J., S.J. Persaud, and P.M. Jones, Stem cell therapy for diabetes: do we need to make beta cells? J Endocrinol, 2004. 183(3): p. 437-43.
Fujikawa, T., et al., Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol, 2005. 166(6): p. 1781-91.
Yang, K., et al., Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells. Cardiovasc Diabetol, 2010. 9: p. 66.
Chen, N.X., et al., High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant, 2006. 21(12): p. 3435-42.
| Files | ||
| Issue | Vol 7, No 3 (2013) | |
| Section | Articles | |
| Keywords | ||
| Differentiation Glucose Proliferation Regulation Stem cell therapy | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
